• Otsuka – Webinar – Treatment options for fragile AML patients

    Find more information and register using this link. 16.30 | Welcome, Ivar Haukeland, Brand Manager, Otsuka Pharma Scandinavia AB 16.35 | Early Nordic experience with AML therapies, Professor Bjørn Tore Gjertsen, Bergen 16.55 | The evolving AML treatment landscape, Professor Gail Roboz, New York. 17.20 | Questions and discussion, led by Professor Bjørn Tore Gjertsen, […]

  • Germline Predisposition to Myeloid Neoplasms – Case discussions

    Join the MDR for patients with germline predisposition for hematological malignancies. This meeting is for clinicians within the Nordics.via this Zoom-link. If you want to discuss a case,  please send 1-2 summary slides with the most important information to Panagiotis Baliakas (panagiotis.baliakas@igp.uu.se), Uppsala, Sweden.

  • Germline Predisposition to Myeloid Neoplasms – Case discussions

    Join the MDR for patients with germline predisposition for hematological malignancies. This meeting is for clinicians within the Nordics.via this Zoom-link. If you want to discuss a case,  please send 1-2 summary slides with the most important information to Panagiotis Baliakas (panagiotis.baliakas@igp.uu.se), Uppsala, Sweden.